Dr. Traver is a patent attorney with experience in the areas of chemistry, pharmaceuticals and biotechnology.
His practice emphasizes all aspects of domestic and foreign patent prosecution in pharmaceuticals, chemistry, biochemistry, therapeutic and diagnostic methods, nutraceuticals, personalized medicine and digital health, as well as licensing, opinions, and due diligence reviews.
Prior to joining Sheridan Ross, Dr. Traver conducted toxicological and molecular research on the role of phase II metabolism in cancer, and the efficacy of anti-cancer compounds. He also teaches patent law in the Bioinnovation and Entrepreneurship Program at the University of Colorado, Denver.
University of Colorado (J.D., 2000)
University of Southern California (Ph.D., Pharmaceutical Science, 1997)
University of Colorado (B.S., Pharmacy, with honors, 1988)
United States Patent and Trademark Office, 2001
United States Federal District Court, District of Colorado, 2000
American Bar Association
Colorado Bar Association
Denver Bar Association
American Intellectual Property Law Association (AIPLA)
All University Predoctoral Merit Fellow, 1989-1991
Pharmaceutical Manufacturers Association, Advanced Predoctoral Fellow, Pharmacology/Toxicology, 1992
Managing Editor, University of Colorado Law Review, 1999-2000